Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sonnet Biotherapeutics Holdings Inc
(NQ:
SONN
)
1.650
-0.070 (-4.07%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Jun 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
10,870
Open
1.850
Bid (Size)
1.600 (22)
Ask (Size)
1.950 (5)
Prev. Close
1.720
Today's Range
1.630 - 1.850
52wk Range
1.080 - 19.25
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Sonnet BioTherapeutics Announces the Generation and Characterization of Two Novel Immunotherapeutic Pipeline Drug Candidates, SON-1411 and SON-1400, Each Containing a Variant IL-18 Domain
June 13, 2024
From
Sonnet BioTherapeutics Holdings, Inc.
Via
GlobeNewswire
Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting
May 28, 2024
From
Sonnet BioTherapeutics Holdings, Inc.
Via
GlobeNewswire
Performance
YTD
-6.25%
-6.25%
1 Month
-10.33%
-10.33%
3 Month
-26.99%
-26.99%
6 Month
+14.19%
+14.19%
1 Year
-88.92%
-88.92%
More News
Read More
Sonnet BioTherapeutics Provides Fiscal Year 2023 Business Overview
October 31, 2023
Via
ACCESSWIRE
Sonnet BioTherapeutics Announces Review of Strategic Alternatives
May 22, 2024
Via
ACCESSWIRE
Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 as Monotherapy or Combined with an anti-PD-L1, along with an Increase in the Dose-Escalation Target
May 20, 2024
Via
ACCESSWIRE
SONN Stock Earnings: Sonnet BioTherapeutics Misses EPS for Q2 2024
May 15, 2024
Via
InvestorPlace
Sonnet BioTherapeutics Provides Fiscal Year 2024 Second Quarter and Year-to-Date Business and Earnings Update
May 14, 2024
Via
ACCESSWIRE
Sonnet BioTherapeutics Announces Participation in the EF Hutton Annual Global Conference
May 06, 2024
Via
ACCESSWIRE
Sonnet BioTherapeutics to Present Preclinical Data on SON-080 for Chemotherapy-Induced Peripheral Neuropathy (CIPN) at the AACR 2024 Annual Meeting
March 19, 2024
Via
ACCESSWIRE
Sonnet BioTherapeutics Announces Early Safety Data from the Company’s Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Met the Study’s Initial Pre-Specified Objective
March 11, 2024
Via
ACCESSWIRE
Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy Volunteers
February 29, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 14, 2024
Via
Benzinga
Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update
February 14, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 13, 2024
Via
Benzinga
Sonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor Immunotherapy
December 21, 2023
Via
ACCESSWIRE
Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update
December 14, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 28, 2023
Via
Benzinga
What's Happening With Sonnet BioTherapeutics (SONN) Shares?
October 26, 2023
Via
Benzinga
Dow Falls Over 100 Points; Alphabet Shares Tumble After Q3 Results
October 25, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 25, 2023
Via
Benzinga
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 25, 2023
Via
Benzinga
Crude Oil Edges Higher; Thermo Fisher Scientific Cuts FY23 Forecast
October 25, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Sonnet BioTherapeutics (SONN) Stock Is Getting Hammered
October 25, 2023
Via
Benzinga
EVGO Stock Slips as TD Cowen Downgrades EVgo
October 25, 2023
Via
InvestorPlace
Nasdaq Down 1.5%; Microsoft Posts Upbeat Results
October 25, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
